Vicus Capital
Source: SEC Form 13F · as of Mar 2026Vicus Capital holds 11 biotech & pharma companies tracked by BioSniper, totaling $5.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$5.8M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 4,894 | $1.2M |
| ABBVAbbVie Inc. | 3,202 | $696K |
| MRKMerck & Co., Inc. | 5,132 | $617K |
| GMOptec International, Inc. | 8,199 | $611K |
| GILDGILEAD SCIENCES, INC. | 4,383 | $611K |
| LLYELI LILLY & Co | 516 | $475K |
| ABTABBOTT LABORATORIES | 4,436 | $455K |
| NVSNovartis AG | 2,250 | $344K |
| PFEPFIZER INC | 9,629 | $270K |
| MCKMcKesson Corporation | 312 | $270K |
| BMYBRISTOL MYERS SQUIBB CO | 4,305 | $261K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.